About Pantson Pharma Private Limited
Data last updated:
Pantson Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2012PTC235942. Its GSTIN is 27AAGCP8269H1ZW (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Monica Pant and Urmila Devi Vemula.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.01 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹50.19 Lakh (net margin 5%) and EBITDA of ₹1.36 Cr (EBITDA margin 13.6%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years and 30% over five years.
The company has about 25 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Pantson Pharma. As per MCA filings, the company has open charges of ₹8.7 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pantsonpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressA – 167 Ttc Industrial Area, MIDC Khairane Navi Mumbai, Thane, Maharashtra, India – 400705
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pantson Pharma Private Limited
The main business activity of Pantson Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pantson Pharma Private Limited FY 2025 filings available
Pantson Pharma Private Limited reported revenue of ₹10.01 Cr (up 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pantson Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 12% growth in the latest year. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pantson Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.36 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹50.19 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pantson Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pantson Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pantson Pharma Private Limited
Pantson Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saturn Formulations Private Limited | ₹10.09 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Chandigarh, India |
| H.L.Healthcare Private Limited | ₹10.08 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | Jalandhar, Punjab, India |
| Vaividhya Lifescience Private Limited | ₹10.03 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Kadi, Gujarat, India |
| Lustre Pharmaceuticals Private Limited | ₹10.03 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Ahmedabad, Gujarat, India |
| Medorganics India Private Limited | ₹10.02 Cr (FY 2024) | •••• | •••• | 15.0% | •••• | Mangalore, Karnataka, India |
| Pantson Pharma Private Limited this company | ₹10.01 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Thane, Maharashtra, India |
| Eucrasia Healthcare Private Limited | ₹10.01 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Ambala, Haryana, India |
| Zenon Healthcare Limited | ₹10 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Ahmedabad, Gujarat, India |
| Deepkamal Health Services Private Limited | ₹10 Cr (FY 2025) | •••• | •••• | 83.0% | •••• | Mumbai, Maharashtra, India |
| Frankwinn Formulations Limited | ₹9.98 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Penamaluru Mandal, Andhra Pradesh, India |
| I G Homoeo Remedies Private Limited | ₹9.97 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Pantson Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pantson Pharma Private Limited
Pantson Pharma Private Limited is audited by DILEEP & PRITHVI for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DILEEP & PRITHVI | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pantson Pharma Private Limited
Pantson Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monica Pant | Director | 04 Mar 2019 | 7 Years 7 Months | Current |
| Urmila Devi Vemula Also directs: Rinica Pharma Private Limited | Director | 01 Jul 2021 | 5 Years 3 Months | Current |
Ownership and Shareholding of Pantson Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pantson Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2023 | Sidbi | ₹5 Cr | Open |
| 15 Apr 2022 | Axis Bank Limited | ₹3.7 Cr | Open |
Total charge records: 2 View all charges
Associated Brands with Pantson Pharma Private Limited
Pantson Pharma operates one associated brand: Pantson Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, R&D, and global distribution of medicines with a focus on quality and affordability. | pantsonpharma.com |
Employees and EPFO Compliance at Pantson Pharma Private Limited
Pantson Pharma Private Limited has a workforce of 25 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Pantson Pharma Private Limited
Pantson Pharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Rinica Pharma Private Limited | U74999MH2014PTC256823 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Pantson Pharma Private Limited
Pantson Pharma Private Limited has 6 board changes on record since 2012: 4 appointments and 2 cessations. The latest: Mousumi Satyanarayana Vemula ceased to be Director on 01 Jul 2021.
Credit Ratings, Litigation & Regulatory Alerts for Pantson Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pantson Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pantson Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pantson Pharma Private Limited
Pantson Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCP8269H1ZW | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pantson Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pantson Pharma Private Limited
Pantson Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 September 2012 (14+ years old) and is registered under CIN U74120MH2012PTC235942.
Pantson Pharma reported revenue of ₹10.01 Cr for FY 2024 (up 12% YoY).
Pantson Pharma has 2 current directors:
- Monica Pant - Director
- Urmila Devi Vemula - Director
Pantson Pharma reported a net profit of ₹50.19 Lakh (net margin 5%) and EBITDA of ₹1.36 Cr (EBITDA margin 13.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pantson Pharma is 41% over three years and 30% over five years. In the latest year (FY 2024) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pantson Pharma is 27AAGCP8269H1ZW, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pantson Pharma is U74120MH2012PTC235942. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pantson Pharma was incorporated on 20 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Pantson Pharma by revenue are Saturn Formulations Private Limited, H.L.Healthcare Private Limited, Vaividhya Lifescience Private Limited, Lustre Pharmaceuticals Private Limited, Medorganics India Private Limited and 5 more, all in the Pharma industry (Formulations).
Mousumi Satyanarayana Vemula ceased to be Director on 01 Jul 2021. Urmila Devi Vemula was appointed as Director on 01 Jul 2021. Mayank Pant ceased to be Director on 04 Mar 2019. Pantson Pharma has 6 board changes on record in total.
Pantson Pharma can be reached through the website pantsonpharma.com. Its registered office is in Thane, Maharashtra, India.